David Berry, Valo Health CEO
September 25, 2023 10:20 AM EDTUpdated September 29, 11:58 PM
Deals

No­vo signs up for near­ly a dozen car­diometa­bol­ic pro­grams out of Va­lo Health

Kyle LaHucik

Senior Reporter

No­vo Nordisk will broad­en its car­diometa­bol­ic pipeline by pair­ing up with ma­chine learn­ing and drug dis­cov­ery start­up Va­lo Health in a deal that builds on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times